Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-25 @ 2:40 AM
NCT ID:
NCT00754533
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years
* Patient hospitalized at Limoges University Hospital, cardiology department, for acute coronary syndrome:
* with or without ST segment elevation
* with or without elevated troponin
* with or without revascularization
* Patients stabilized with medication without rest myocardial ischemia
* Left ventricular ejection fraction \>= 35% measured on echocardiography
* Patient who have signed and dated informed consent
* Patient who can do a maximal metabolic exercise test
Exclusion Criteria:
* Contraindication for exercise testing:
* acute myocardial infraction \< 5 days
* unstable angina
* left main coronary stenosis
* uncontrolled cardiac arrhythmia
* uncontrolled symptomatic heart failure
* acute pulmonary embolism or phlebitis
* acute myocarditis, pericarditis or endocarditis
* patient's physical inability or refusal
* left ventricular thrombus after acute myocardial infarction
* pulmonary hypertension \> 60 mmHg
* uncontrolled arterial hypertension
* Age \< 18 years
* Patient revascularized by coronary artery bypass grafting after acute coronary syndrome
* Chronic supraventricular arrhythmias
* Impossible physical exercise
* Patient who can't understand the protocol or who refused to give his consent
* Patient who already attended a training program over the last 6 months
* Patient with difficult follow-up
* Current participation in another study
* Patient under guardianship
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00754533
Study Brief:
Protocol Section:
NCT00754533